EGFR and prostate cancer: As anticipated, the KEGG analysis unveiled eight different malignancies, encompassing chronic myeloid leukemia, prostate cancer, renal cell carcinoma, acute myeloid leukemia, glioma, small cell lung cancer, pancreatic cancer, and non-small cell lung cancer, in the top 20 rankings, in addition to pathways intricately linked to carcinogenesis such as ErbB [215], Wnt [216], and insulin [217], all of which are well-recognized contributors to EC.